Susan G. Komen has a rich history of more than 30 years in public policy and advocacy. In order to achieve our mission we believe that scientific progress must be complemented by sound public policy and advocacy. Through government action, broad, systemic, lasting change can be made in the fight against breast cancer. This means that Komen—as a patient advocacy organization with first-hand knowledge of how breast cancer touches local communities—must engage policymakers and government as partners in our efforts to end breast cancer forever.
To advance our policy priorities, Komen works with our staff, volunteers, grantees, researchers and friends in communities across the United States, to ensure breast cancer is a priority among policymakers at the federal, state and local levels and to increase access to affordable, high-quality breast health and cancer care services.
Find information about Susan G. Komen’s advocacy efforts and priorities on a national level at https://ww5.komen.org/WhatWeDo/Advocacy/Advocacy.html.
Learn more about the issues that Susan G. Komen is working on at https://ww5.komen.org/Advocacy-Resources.aspx.
Sign Susan G. Komen’s petition to defend the Breast Cancer Bill of Rights.
Locally, in Oregon and SW Washington:
- Our focus is on state funding of the Oregon ScreenWise (Breast and Cervical Cancer Early Detection) Program. We are collaborating with partners to ensure that screening and diagnostic programs are available to all qualifying women starting at age 40.
- Sign our online petition and share that you support state funding of ScreenWise, the state’s breast and cervical cancer program: https://www.surveymonkey.com/r/SWsurvey2020
- Join us in Salem on Thursday, February 27th, as Komen combines forces with ACS CAN on their Cancer Action Day. After a morning of training, we’ll meet with Oregon state legislators to make sure they understand the importance of funding ScreenWise. RSVP here!
- We are part of a coalition in support of Oregon House Bill 4102, which will improve step therapy and prior authorization protocols.